These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
|
x
|
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
|
|
|
For the Quarterly Period Ended March 31, 2018
|
||
|
Or
|
||
|
o
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
|
|
|
For the Transition Period from
to
.
|
||
|
|
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
38-2687639
(IRS Employer
Identification No.)
|
|
Large accelerated filer
|
x
|
|
Accelerated filer
|
o
|
|
|
|
|
|
|
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
|
|
|
|
|
|
|
|
|
|
|
|
Smaller reporting company
|
o
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
|
o
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
Assets
|
|
(unaudited)
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
36,670
|
|
|
$
|
27,580
|
|
|
Receivables, net of reserves of approximately $4.1 million as of March 31, 2018 and December 31, 2017, respectively
|
|
128,850
|
|
|
112,220
|
|
||
|
Inventories
|
|
156,560
|
|
|
155,350
|
|
||
|
Prepaid expenses and other current assets
|
|
10,840
|
|
|
16,120
|
|
||
|
Total current assets
|
|
332,920
|
|
|
311,270
|
|
||
|
Property and equipment, net
|
|
188,440
|
|
|
190,250
|
|
||
|
Goodwill
|
|
320,210
|
|
|
319,390
|
|
||
|
Other intangibles, net
|
|
189,260
|
|
|
194,220
|
|
||
|
Deferred income taxes
|
|
5,280
|
|
|
9,100
|
|
||
|
Other assets
|
|
9,020
|
|
|
8,970
|
|
||
|
Total assets
|
|
$
|
1,045,130
|
|
|
$
|
1,033,200
|
|
|
Liabilities and Shareholders' Equity
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
73,020
|
|
|
$
|
72,410
|
|
|
Accrued liabilities
|
|
44,720
|
|
|
49,470
|
|
||
|
Total current liabilities
|
|
117,740
|
|
|
121,880
|
|
||
|
Long-term debt, net
|
|
301,710
|
|
|
303,080
|
|
||
|
Deferred income taxes
|
|
5,710
|
|
|
5,650
|
|
||
|
Other long-term liabilities
|
|
54,190
|
|
|
58,570
|
|
||
|
Total liabilities
|
|
479,350
|
|
|
489,180
|
|
||
|
Preferred stock, $0.01 par: Authorized 100,000,000 shares;
Issued and outstanding: None |
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par: Authorized 400,000,000 shares;
Issued and outstanding: 45,924,244 shares at March 31, 2018 and 45,724,453 shares at December 31, 2017 |
|
460
|
|
|
460
|
|
||
|
Paid-in capital
|
|
822,770
|
|
|
823,850
|
|
||
|
Accumulated deficit
|
|
(238,640
|
)
|
|
(262,960
|
)
|
||
|
Accumulated other comprehensive loss
|
|
(18,810
|
)
|
|
(17,330
|
)
|
||
|
Total shareholders' equity
|
|
565,780
|
|
|
544,020
|
|
||
|
Total liabilities and shareholders' equity
|
|
$
|
1,045,130
|
|
|
$
|
1,033,200
|
|
|
|
|
Three months ended
March 31, |
||||||
|
|
|
2018
|
|
2017
|
||||
|
Net sales
|
|
$
|
217,100
|
|
|
$
|
199,830
|
|
|
Cost of sales
|
|
(156,720
|
)
|
|
(148,010
|
)
|
||
|
Gross profit
|
|
60,380
|
|
|
51,820
|
|
||
|
Selling, general and administrative expenses
|
|
(25,170
|
)
|
|
(35,910
|
)
|
||
|
Operating profit
|
|
35,210
|
|
|
15,910
|
|
||
|
Other expense, net:
|
|
|
|
|
||||
|
Interest expense
|
|
(3,700
|
)
|
|
(3,550
|
)
|
||
|
Other expense, net
|
|
(560
|
)
|
|
(780
|
)
|
||
|
Other expense, net
|
|
(4,260
|
)
|
|
(4,330
|
)
|
||
|
Income before income tax expense
|
|
30,950
|
|
|
11,580
|
|
||
|
Income tax expense
|
|
(6,630
|
)
|
|
(4,590
|
)
|
||
|
Net income
|
|
$
|
24,320
|
|
|
$
|
6,990
|
|
|
Basic earnings per share:
|
|
|
|
|
||||
|
Net income per share
|
|
$
|
0.53
|
|
|
$
|
0.15
|
|
|
Weighted average common shares—basic
|
|
45,779,966
|
|
|
45,570,495
|
|
||
|
Diluted earnings per share:
|
|
|
|
|
||||
|
Net income per share
|
|
$
|
0.53
|
|
|
$
|
0.15
|
|
|
Weighted average common shares—diluted
|
|
46,229,337
|
|
|
45,908,958
|
|
||
|
|
|
Three months ended
March 31, |
||||||
|
|
|
2018
|
|
2017
|
||||
|
Net income
|
|
$
|
24,320
|
|
|
$
|
6,990
|
|
|
Other comprehensive income (loss):
|
|
|
|
|
||||
|
Defined benefit pension and postretirement plans (Note 14)
|
|
200
|
|
|
170
|
|
||
|
Foreign currency translation
|
|
2,360
|
|
|
1,800
|
|
||
|
Derivative instruments (Note 9)
|
|
(4,040
|
)
|
|
380
|
|
||
|
Total other comprehensive income (loss)
|
|
(1,480
|
)
|
|
2,350
|
|
||
|
Total comprehensive income
|
|
$
|
22,840
|
|
|
$
|
9,340
|
|
|
|
|
Three months ended March 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Cash Flows from Operating Activities:
|
|
|
|
|
||||
|
Net income
|
|
$
|
24,320
|
|
|
$
|
6,990
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
||||
|
(Gain) loss on dispositions of assets
|
|
(10
|
)
|
|
4,170
|
|
||
|
Depreciation
|
|
6,330
|
|
|
5,800
|
|
||
|
Amortization of intangible assets
|
|
4,910
|
|
|
4,990
|
|
||
|
Amortization of debt issue costs
|
|
470
|
|
|
350
|
|
||
|
Deferred income taxes
|
|
5,010
|
|
|
1,870
|
|
||
|
Non-cash compensation expense
|
|
1,220
|
|
|
1,470
|
|
||
|
Increase in receivables
|
|
(16,160
|
)
|
|
(7,590
|
)
|
||
|
Increase in inventories
|
|
(840
|
)
|
|
(420
|
)
|
||
|
Decrease in prepaid expenses and other assets
|
|
5,330
|
|
|
8,070
|
|
||
|
Decrease in accounts payable and accrued liabilities
|
|
(15,140
|
)
|
|
(3,160
|
)
|
||
|
Other operating activities
|
|
800
|
|
|
(570
|
)
|
||
|
Net cash provided by operating activities
|
|
16,240
|
|
|
21,970
|
|
||
|
Cash Flows from Investing Activities:
|
|
|
|
|
||||
|
Capital expenditures
|
|
(3,170
|
)
|
|
(10,740
|
)
|
||
|
Net proceeds from disposition of property and equipment
|
|
250
|
|
|
30
|
|
||
|
Net cash used for investing activities
|
|
(2,920
|
)
|
|
(10,710
|
)
|
||
|
Cash Flows from Financing Activities:
|
|
|
|
|
||||
|
Repayments of borrowings on term loan facilities
|
|
—
|
|
|
(3,470
|
)
|
||
|
Proceeds from borrowings on revolving credit and accounts receivable facilities
|
|
32,040
|
|
|
186,640
|
|
||
|
Repayments of borrowings on revolving credit and accounts receivable facilities
|
|
(33,970
|
)
|
|
(191,760
|
)
|
||
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes
|
|
(2,300
|
)
|
|
(450
|
)
|
||
|
Other financing activities
|
|
—
|
|
|
(290
|
)
|
||
|
Net cash used for financing activities
|
|
(4,230
|
)
|
|
(9,330
|
)
|
||
|
Cash and Cash Equivalents:
|
|
|
|
|
||||
|
Net increase for the period
|
|
9,090
|
|
|
1,930
|
|
||
|
At beginning of period
|
|
27,580
|
|
|
20,710
|
|
||
|
At end of period
|
|
$
|
36,670
|
|
|
$
|
22,640
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
||||
|
Cash paid for interest
|
|
$
|
470
|
|
|
$
|
3,050
|
|
|
Cash paid for taxes
|
|
$
|
970
|
|
|
$
|
1,230
|
|
|
|
|
Common
Stock
|
|
Paid-in
Capital
|
|
Accumulated
Deficit
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Total
|
||||||||||
|
Balances, December 31, 2017
|
|
$
|
460
|
|
|
$
|
823,850
|
|
|
$
|
(262,960
|
)
|
|
$
|
(17,330
|
)
|
|
$
|
544,020
|
|
|
Net income
|
|
—
|
|
|
—
|
|
|
24,320
|
|
|
—
|
|
|
24,320
|
|
|||||
|
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,480
|
)
|
|
(1,480
|
)
|
|||||
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes
|
|
—
|
|
|
(2,300
|
)
|
|
—
|
|
|
—
|
|
|
(2,300
|
)
|
|||||
|
Non-cash compensation expense
|
|
—
|
|
|
1,220
|
|
|
—
|
|
|
—
|
|
|
1,220
|
|
|||||
|
Balances, March 31, 2018
|
|
$
|
460
|
|
|
$
|
822,770
|
|
|
$
|
(238,640
|
)
|
|
$
|
(18,810
|
)
|
|
$
|
565,780
|
|
|
|
|
Three months ended March 31,
|
||||||
|
Customer End Markets
|
|
2018
|
|
2017
|
||||
|
Consumer
|
|
$
|
64,730
|
|
|
$
|
58,880
|
|
|
Aerospace
|
|
45,810
|
|
|
45,420
|
|
||
|
Industrial
|
|
54,350
|
|
|
49,290
|
|
||
|
Oil and gas
|
|
52,210
|
|
|
46,240
|
|
||
|
Total net sales
|
|
$
|
217,100
|
|
|
$
|
199,830
|
|
|
|
Packaging
|
|
Aerospace
|
|
Specialty Products
|
|
Total
|
||||||||
|
Balance, December 31, 2017
|
$
|
166,400
|
|
|
$
|
146,430
|
|
|
$
|
6,560
|
|
|
$
|
319,390
|
|
|
Foreign currency translation and other
|
820
|
|
|
—
|
|
|
—
|
|
|
820
|
|
||||
|
Balance, March 31, 2018
|
$
|
167,220
|
|
|
$
|
146,430
|
|
|
$
|
6,560
|
|
|
$
|
320,210
|
|
|
|
|
As of March 31, 2018
|
|
As of December 31, 2017
|
||||||||||||
|
Intangible Category by Useful Life
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
||||||||
|
Finite-lived intangible assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Customer relationships, 5 – 12 years
|
|
$
|
73,810
|
|
|
$
|
(42,900
|
)
|
|
$
|
73,910
|
|
|
$
|
(41,000
|
)
|
|
Customer relationships, 15 – 25 years
|
|
132,230
|
|
|
(53,600
|
)
|
|
132,230
|
|
|
(51,880
|
)
|
||||
|
Total customer relationships
|
|
206,040
|
|
|
(96,500
|
)
|
|
206,140
|
|
|
(92,880
|
)
|
||||
|
Technology and other, 1 – 15 years
|
|
57,060
|
|
|
(29,550
|
)
|
|
57,340
|
|
|
(29,120
|
)
|
||||
|
Technology and other, 17 – 30 years
|
|
43,300
|
|
|
(34,020
|
)
|
|
43,300
|
|
|
(33,490
|
)
|
||||
|
Total technology and other
|
|
100,360
|
|
|
(63,570
|
)
|
|
100,640
|
|
|
(62,610
|
)
|
||||
|
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Trademark/Trade names
|
|
42,930
|
|
|
—
|
|
|
42,930
|
|
|
—
|
|
||||
|
Total other intangible assets
|
|
$
|
349,330
|
|
|
$
|
(160,070
|
)
|
|
$
|
349,710
|
|
|
$
|
(155,490
|
)
|
|
|
|
Three months ended March 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Technology and other, included in cost of sales
|
|
$
|
1,240
|
|
|
$
|
1,350
|
|
|
Customer relationships, included in selling, general and administrative expenses
|
|
3,670
|
|
|
3,640
|
|
||
|
Total amortization expense
|
|
$
|
4,910
|
|
|
$
|
4,990
|
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
Finished goods
|
|
$
|
83,730
|
|
|
$
|
86,310
|
|
|
Work in process
|
|
26,780
|
|
|
24,580
|
|
||
|
Raw materials
|
|
46,050
|
|
|
44,460
|
|
||
|
Total inventories
|
|
$
|
156,560
|
|
|
$
|
155,350
|
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
Land and land improvements
|
|
$
|
15,540
|
|
|
$
|
15,500
|
|
|
Buildings
|
|
75,850
|
|
|
73,550
|
|
||
|
Machinery and equipment
|
|
306,370
|
|
|
303,880
|
|
||
|
|
|
397,760
|
|
|
392,930
|
|
||
|
Less: Accumulated depreciation
|
|
209,320
|
|
|
202,680
|
|
||
|
Property and equipment, net
|
|
$
|
188,440
|
|
|
$
|
190,250
|
|
|
|
|
Three months ended March 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Depreciation expense, included in cost of sales
|
|
$
|
5,810
|
|
|
$
|
5,200
|
|
|
Depreciation expense, included in selling, general and administrative expenses
|
|
520
|
|
|
600
|
|
||
|
Total depreciation expense
|
|
$
|
6,330
|
|
|
$
|
5,800
|
|
|
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
4.875% Senior Notes due October 2025
|
|
$
|
300,000
|
|
|
$
|
300,000
|
|
|
Credit Agreement
|
|
8,970
|
|
|
10,810
|
|
||
|
Debt issuance costs
|
|
(7,260
|
)
|
|
(7,730
|
)
|
||
|
Long-term debt, net
|
|
$
|
301,710
|
|
|
$
|
303,080
|
|
|
Year
|
|
Percentage
|
|
|
2020
|
|
102.438
|
%
|
|
2021
|
|
101.219
|
%
|
|
2022 and thereafter
|
|
100.000
|
%
|
|
|
|
March 31, 2018
|
|
December 31, 2017
|
||||||||||||
|
|
|
Carrying Amount
|
|
Fair Value
|
|
Carrying Amount
|
|
Fair Value
|
||||||||
|
Senior Notes
|
|
$
|
300,000
|
|
|
$
|
289,500
|
|
|
$
|
300,000
|
|
|
$
|
300,750
|
|
|
Revolving credit facility
|
|
8,970
|
|
|
8,750
|
|
|
10,810
|
|
|
10,490
|
|
||||
|
|
|
|
|
Asset / (Liability) Derivatives
|
||||||
|
Derivatives designated as hedging instruments
|
|
Balance Sheet Caption
|
|
March 31,
2018 |
|
December 31,
2017 |
||||
|
Net Investment Hedges
|
|
|
|
|
|
|
||||
|
Cross-currency swaps
|
|
Other long-term liabilities
|
|
$
|
(9,340
|
)
|
|
$
|
(4,110
|
)
|
|
|
Amount of Loss Recognized
in AOCI on Derivative (Effective Portion, net of tax) |
|
|
Amount of Loss Reclassified
from AOCI into Earnings |
|||||||||||||
|
|
|
|
|
Three months ended
March 31, |
|||||||||||||
|
|
As of
March 31,
2018
|
|
As of December 31, 2017
|
|
Location of Loss Reclassified from AOCI into Earnings (Effective Portion)
|
|
2018
|
|
2017
|
||||||||
|
Net Investment Hedges
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cross-currency swaps
|
$
|
(7,210
|
)
|
|
$
|
(3,170
|
)
|
|
Other expense, net
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Cash Flow Hedges
|
|
|
|
|
|
|
|
|
|
||||||||
|
Interest rate swaps
|
$
|
—
|
|
|
$
|
—
|
|
|
Interest expense
|
|
$
|
—
|
|
|
$
|
(250
|
)
|
|
|
Description
|
|
Frequency
|
|
Asset / (Liability)
|
|
Quoted Prices in Active Markets for Identical Assets
(Level 1) |
|
Significant Other Observable Inputs
(Level 2) |
|
Significant Unobservable Inputs
(Level 3) |
||||||||
|
March 31, 2018
|
Cross-currency swaps
|
|
Recurring
|
|
$
|
(9,340
|
)
|
|
$
|
—
|
|
|
$
|
(9,340
|
)
|
|
$
|
—
|
|
|
December 31, 2017
|
Cross-currency swaps
|
|
Recurring
|
|
$
|
(4,110
|
)
|
|
$
|
—
|
|
|
$
|
(4,110
|
)
|
|
$
|
—
|
|
|
|
|
Claims
pending at
beginning of
period
|
|
Claims filed
during
period
|
|
Claims
dismissed
during
period
|
|
Claims
settled
during
period
|
|
Claims
pending at end of period |
|
Average
settlement
amount per
claim during
period
|
|
Total defense
costs during
period
|
|||||||||
|
Three Months Ended March 31, 2018
|
|
5,256
|
|
|
50
|
|
|
389
|
|
|
4
|
|
|
4,913
|
|
|
$
|
14,750
|
|
|
$
|
550,000
|
|
|
Fiscal Year Ended December 31, 2017
|
|
5,339
|
|
|
173
|
|
|
231
|
|
|
25
|
|
|
5,256
|
|
|
$
|
8,930
|
|
|
$
|
2,280,000
|
|
|
|
|
Compensatory
|
||||
|
Range of damages sought (dollars in millions)
|
|
$0.0 to $0.6
|
|
$0.6 to $5.0
|
|
$5.0+
|
|
Number of claims
|
|
—
|
|
13
|
|
46
|
|
|
|
Three months ended
March 31, |
||||||
|
|
|
2018
|
|
2017
|
||||
|
Net Sales
|
|
|
|
|
||||
|
Packaging
|
|
$
|
88,200
|
|
|
$
|
80,960
|
|
|
Aerospace
|
|
45,810
|
|
|
45,420
|
|
||
|
Specialty Products
|
|
83,090
|
|
|
73,450
|
|
||
|
Total
|
|
$
|
217,100
|
|
|
$
|
199,830
|
|
|
Operating Profit (Loss)
|
|
|
|
|
||||
|
Packaging
|
|
$
|
19,580
|
|
|
$
|
16,900
|
|
|
Aerospace
|
|
5,080
|
|
|
5,060
|
|
||
|
Specialty Products
|
|
9,650
|
|
|
1,510
|
|
||
|
Corporate income (expense)
(a)
|
|
900
|
|
|
(7,560
|
)
|
||
|
Total
|
|
$
|
35,210
|
|
|
$
|
15,910
|
|
|
(a)
|
During the first quarter of 2018, the Company removed an obligation from its balance sheet, resulting in an approximate
$8.2 million
non-cash reduction in selling, general and administrative expenses. See Note
10
, "
Commitments and Contingencies
," for further details.
|
|
|
|
Number of
Stock Options |
|
Weighted Average Option Price
|
|
Average Remaining Contractual Life (Years)
|
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 1, 2018
|
|
206,854
|
|
|
$
|
13.19
|
|
|
|
|
|
||
|
Granted
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Exercised
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Cancelled
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Expired
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Outstanding at March 31, 2018
|
|
206,854
|
|
|
$
|
13.19
|
|
|
6.3
|
|
$
|
2,700,523
|
|
|
|
|
Number of Unvested RSUs
|
|
Weighted Average Grant Date Fair Value
|
|
Average Remaining Contractual Life (Years)
|
|
Aggregate Intrinsic Value
|
|||||
|
Outstanding at January 1, 2018
|
|
726,936
|
|
|
$
|
22.60
|
|
|
|
|
|
||
|
Granted
|
|
33,678
|
|
|
22.76
|
|
|
|
|
|
|||
|
Vested
|
|
(288,895
|
)
|
|
22.18
|
|
|
|
|
|
|||
|
Cancelled
|
|
(13,971
|
)
|
|
21.67
|
|
|
|
|
|
|||
|
Outstanding at March 31, 2018
|
|
457,748
|
|
|
$
|
22.90
|
|
|
1.1
|
|
$
|
12,015,885
|
|
|
|
|
Three months ended
March 31, |
||||
|
|
|
2018
|
|
2017
|
||
|
Weighted average common shares—basic
|
|
45,779,966
|
|
|
45,570,495
|
|
|
Dilutive effect of restricted stock units
|
|
358,583
|
|
|
283,839
|
|
|
Dilutive effect of stock options
|
|
90,788
|
|
|
54,624
|
|
|
Weighted average common shares—diluted
|
|
46,229,337
|
|
|
45,908,958
|
|
|
|
|
Pension Plans
|
||||||
|
|
|
Three months ended
March 31, |
||||||
|
|
|
2018
|
|
2017
|
||||
|
Service costs
|
|
$
|
300
|
|
|
$
|
280
|
|
|
Interest costs
|
|
300
|
|
|
320
|
|
||
|
Expected return on plan assets
|
|
(430
|
)
|
|
(370
|
)
|
||
|
Amortization of net loss
|
|
250
|
|
|
250
|
|
||
|
Net periodic benefit cost
|
|
$
|
420
|
|
|
$
|
480
|
|
|
|
|
Defined Benefit Plans
|
|
Derivative Instruments
|
|
Foreign Currency Translation
|
|
Total
|
||||||||
|
Balance, December 31, 2017
|
|
$
|
(10,450
|
)
|
|
$
|
(3,170
|
)
|
|
$
|
(3,710
|
)
|
|
$
|
(17,330
|
)
|
|
Net unrealized gains (losses) arising during the period
(a)
|
|
—
|
|
|
(4,040
|
)
|
|
2,360
|
|
|
(1,680
|
)
|
||||
|
Less: Net realized losses reclassified to net income
(b)
|
|
(200
|
)
|
|
—
|
|
|
—
|
|
|
(200
|
)
|
||||
|
Net current-period other comprehensive income (loss)
|
|
200
|
|
|
(4,040
|
)
|
|
2,360
|
|
|
(1,480
|
)
|
||||
|
Balance, March 31, 2018
|
|
$
|
(10,250
|
)
|
|
$
|
(7,210
|
)
|
|
$
|
(1,350
|
)
|
|
$
|
(18,810
|
)
|
|
(a)
|
Derivative instruments, net of income tax of approximately
$1.2 million
. See Note
9
, "
Derivative Instruments
," for further details.
|
|
(b)
|
Defined benefit plans, net of income tax of approximately
$0.1 million
. See Note
14
, "
Defined Benefit Plans
," for further details.
|
|
|
|
Defined Benefit Plans
|
|
Derivative Instruments
|
|
Foreign Currency Translation
|
|
Total
|
||||||||
|
Balance, December 31, 2016
|
|
$
|
(12,120
|
)
|
|
$
|
(2,520
|
)
|
|
$
|
(9,760
|
)
|
|
$
|
(24,400
|
)
|
|
Net unrealized gains arising during the period
(a)
|
|
—
|
|
|
240
|
|
|
1,800
|
|
|
2,040
|
|
||||
|
Less: Net realized losses reclassified to net income
(b)
|
|
(170
|
)
|
|
(140
|
)
|
|
—
|
|
|
(310
|
)
|
||||
|
Net current-period other comprehensive income
|
|
170
|
|
|
380
|
|
|
1,800
|
|
|
2,350
|
|
||||
|
Balance, March 31, 2017
|
|
$
|
(11,950
|
)
|
|
$
|
(2,140
|
)
|
|
$
|
(7,960
|
)
|
|
$
|
(22,050
|
)
|
|
(a)
|
Derivative instruments, net of income tax of approximately
$0.1 million
. See Note
9
, "
Derivative Instruments
," for further details.
|
|
(b)
|
Defined benefit plans, net of income tax of approximately
$0.1 million
. See Note
14
, "
Defined Benefit Plans
," for further details. Derivative instruments, net of income tax of approximately
$0.1 million
. See Note
9
, "
Derivative Instruments
," for further details.
|
|
|
Three months ended March 31,
|
||||||||||||
|
|
2018
|
|
As a Percentage
of Net Sales
|
|
2017
|
|
As a Percentage
of Net Sales
|
||||||
|
Net Sales
|
|
|
|
|
|
|
|
||||||
|
Packaging
|
$
|
88,200
|
|
|
40.6
|
%
|
|
$
|
80,960
|
|
|
40.5
|
%
|
|
Aerospace
|
45,810
|
|
|
21.1
|
%
|
|
45,420
|
|
|
22.7
|
%
|
||
|
Specialty Products
|
83,090
|
|
|
38.3
|
%
|
|
73,450
|
|
|
36.8
|
%
|
||
|
Total
|
$
|
217,100
|
|
|
100.0
|
%
|
|
$
|
199,830
|
|
|
100.0
|
%
|
|
Gross Profit
|
|
|
|
|
|
|
|
||||||
|
Packaging
|
$
|
29,230
|
|
|
33.1
|
%
|
|
$
|
25,660
|
|
|
31.7
|
%
|
|
Aerospace
|
11,150
|
|
|
24.3
|
%
|
|
10,800
|
|
|
23.8
|
%
|
||
|
Specialty Products
|
20,000
|
|
|
24.1
|
%
|
|
15,360
|
|
|
20.9
|
%
|
||
|
Total
|
$
|
60,380
|
|
|
27.8
|
%
|
|
$
|
51,820
|
|
|
25.9
|
%
|
|
Selling, General and Administrative Expenses
|
|
|
|
|
|
|
|
||||||
|
Packaging
|
$
|
9,650
|
|
|
10.9
|
%
|
|
$
|
8,760
|
|
|
10.8
|
%
|
|
Aerospace
|
6,070
|
|
|
13.3
|
%
|
|
5,740
|
|
|
12.6
|
%
|
||
|
Specialty Products
|
10,350
|
|
|
12.5
|
%
|
|
13,850
|
|
|
18.9
|
%
|
||
|
Corporate (income) expenses
|
(900
|
)
|
|
N/A
|
|
|
7,560
|
|
|
N/A
|
|
||
|
Total
|
$
|
25,170
|
|
|
11.6
|
%
|
|
$
|
35,910
|
|
|
18.0
|
%
|
|
Operating Profit (Loss)
|
|
|
|
|
|
|
|
||||||
|
Packaging
|
$
|
19,580
|
|
|
22.2
|
%
|
|
$
|
16,900
|
|
|
20.9
|
%
|
|
Aerospace
|
5,080
|
|
|
11.1
|
%
|
|
5,060
|
|
|
11.1
|
%
|
||
|
Specialty Products
|
9,650
|
|
|
11.6
|
%
|
|
1,510
|
|
|
2.1
|
%
|
||
|
Corporate income (expenses)
|
900
|
|
|
N/A
|
|
|
(7,560
|
)
|
|
N/A
|
|
||
|
Total
|
$
|
35,210
|
|
|
16.2
|
%
|
|
$
|
15,910
|
|
|
8.0
|
%
|
|
Depreciation
|
|
|
|
|
|
|
|
||||||
|
Packaging
|
$
|
3,220
|
|
|
3.7
|
%
|
|
$
|
2,880
|
|
|
3.6
|
%
|
|
Aerospace
|
1,660
|
|
|
3.6
|
%
|
|
1,440
|
|
|
3.2
|
%
|
||
|
Specialty Products
|
1,380
|
|
|
1.7
|
%
|
|
1,420
|
|
|
1.9
|
%
|
||
|
Corporate expenses
|
70
|
|
|
N/A
|
|
|
60
|
|
|
N/A
|
|
||
|
Total
|
$
|
6,330
|
|
|
2.9
|
%
|
|
$
|
5,800
|
|
|
2.9
|
%
|
|
Amortization
|
|
|
|
|
|
|
|
||||||
|
Packaging
|
$
|
2,300
|
|
|
2.6
|
%
|
|
$
|
2,390
|
|
|
3.0
|
%
|
|
Aerospace
|
2,160
|
|
|
4.7
|
%
|
|
2,160
|
|
|
4.8
|
%
|
||
|
Specialty Products
|
450
|
|
|
0.5
|
%
|
|
440
|
|
|
0.6
|
%
|
||
|
Corporate expenses
|
—
|
|
|
N/A
|
|
|
—
|
|
|
N/A
|
|
||
|
Total
|
$
|
4,910
|
|
|
2.3
|
%
|
|
$
|
4,990
|
|
|
2.5
|
%
|
|
|
|
|
|
|
|
|
|
|
•
|
increased economic activity primarily in the United States, resulting in increased net sales in each of our reportable segments;
|
|
•
|
continued benefits of leveraging the TBM, primarily related to realignment actions within our Specialty Products reportable segment, which resulted in lower ongoing operating costs following several facility consolidations and closures;
|
|
•
|
the termination of the liability to Metaldyne, resulting in an approximate $8.2 million reduction in selling, general and administrative expenses; and
|
|
•
|
the impact of the Tax Reform Act, contributing to a lower overall effective tax rate.
|
|
|
|
Three months ended March 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Corporate operating expenses
|
|
$
|
5.3
|
|
|
$
|
5.5
|
|
|
Non-cash stock compensation
|
|
1.2
|
|
|
1.5
|
|
||
|
Legacy (income) expenses, net
|
|
(7.4
|
)
|
|
0.6
|
|
||
|
Corporate (income) expenses, net
|
|
$
|
(0.9
|
)
|
|
$
|
7.6
|
|
|
•
|
For the
three months ended March 31, 2018
, the Company generated approximately
$43.1 million
of cash, based on the reported net income of approximately
$24.3 million
and after considering the effects of non-cash items related to depreciation, amortization, (gain) loss on dispositions of assets, changes in deferred income taxes, stock-based compensation and other operating activities. For the
three months ended March 31, 2017
, the Company generated approximately
$25.1 million
in cash flows based on the reported net income of approximately
$7.0 million
and after considering the effects of similar non-cash items.
|
|
•
|
Increases in accounts receivable resulted in a use of cash of approximately
$16.2 million
and
$7.6 million
for the
three months ended March 31, 2018
and
2017
, respectively. The increased use of cash for each of the
three
month periods is due primarily to the timing of sales and collection of cash within the periods. Days sales outstanding of receivables remained flat period-over-period.
|
|
•
|
We increased our investment in inventory by approximately
$0.8 million
and
$0.4 million
for the
three months ended March 31, 2018
and
2017
, respectively, primarily as a result of operating at higher production levels in anticipation of higher customer demand. While our gross inventory levels are higher in 2018 than in 2017, our days sales of inventory have decreased by seven days, as we continue our significant focus on working capital management.
|
|
•
|
Decreases in prepaid expenses and other assets resulted in a cash source of approximately
$5.3 million
and
$8.1 million
for the
three months ended March 31, 2018
and
2017
, respectively, primarily as a result of the timing of payments made for income taxes and certain operating expenses.
|
|
•
|
Decreases in accounts payable and accrued liabilities resulted in a cash use of approximately
$15.1 million
for the
three months ended March 31, 2018
, which includes an approximate $8.2 million non-cash reduction in an obligation during first quarter 2018, and $6.9 million of a decrease primarily resulting from the timing of payments made to suppliers. Decreases in accounts payable and accrued liabilities resulted in a cash use of approximately
$3.2 million
for the
three months ended March 31, 2017
, primarily as a result of timing of payments made to suppliers and the mix of vendors and related terms. Our days accounts payable on hand decreased by five days as of
March 31, 2018
as compared to
March 31, 2017
.
|
|
|
|
|
||
|
|
|
Twelve Months Ended March 31, 2018
|
||
|
Net income
|
|
$
|
48,290
|
|
|
Bank stipulated adjustments:
|
|
|
||
|
Interest expense
|
|
14,550
|
|
|
|
Income tax expense
|
|
37,290
|
|
|
|
Depreciation and amortization
|
|
47,320
|
|
|
|
Non-cash compensation expense
(1)
|
|
6,530
|
|
|
|
Other non-cash expenses or losses
|
|
4,200
|
|
|
|
Non-recurring expenses or costs
(2)
|
|
5,290
|
|
|
|
Extraordinary, non-recurring or unusual gains or losses
|
|
(8,150
|
)
|
|
|
Business and asset dispositions
|
|
1,400
|
|
|
|
Debt financing and extinguishment costs
|
|
6,640
|
|
|
|
Consolidated Bank EBITDA, as defined
|
|
$
|
163,360
|
|
|
|
March 31, 2018
|
|
||
|
Total Indebtedness, as defined
(3)
|
$
|
294,810
|
|
|
|
Consolidated Bank EBITDA, as defined
|
163,360
|
|
|
|
|
Total net leverage ratio
|
1.80
|
|
x
|
|
|
Covenant requirement
|
4.00
|
|
x
|
|
|
|
March 31, 2018
|
|
||
|
Total Senior Secured Indebtedness
(4)
|
$
|
(9,140
|
)
|
|
|
Consolidated Bank EBITDA, as defined
|
163,360
|
|
|
|
|
Senior secured net leverage ratio
|
n/m
|
|
x
|
|
|
Covenant requirement
|
3.50
|
|
x
|
|
|
|
|
Twelve Months Ended March 31, 2018
|
||
|
Interest expense
|
|
$
|
14,550
|
|
|
Bank stipulated adjustments:
|
|
|
||
|
Non-cash amounts attributable to amortization of financing costs
|
|
(1,270
|
)
|
|
|
Total Consolidated Cash Interest Expense, as defined
|
|
$
|
13,280
|
|
|
|
March 31, 2018
|
|
||
|
Consolidated Bank EBITDA, as defined
|
$
|
163,360
|
|
|
|
Total Consolidated Cash Interest Expense, as defined
|
13,280
|
|
|
|
|
Actual interest expense coverage ratio
|
12.30
|
|
x
|
|
|
Covenant requirement
|
3.00
|
|
x
|
|
|
(1)
|
Non-cash compensation expenses resulting from the grant of equity awards
|
|
(2)
|
Non-recurring costs and expenses relating to severance, relocation, restructuring and curtailment expenses.
|
|
(3)
|
Includes $4.0 million of acquisition deferred purchase price.
|
|
(4)
|
Senior secured indebtedness is negative at
March 31, 2018
due to the deduction of certain unrestricted cash and unrestricted permitted investments as allowed under the Credit Agreement.
|
|
3.1(a)
|
|
|
3.2(b)
|
|
|
31.1
|
|
|
31.2
|
|
|
32.1
|
|
|
32.2
|
|
|
101.INS
|
XBRL Instance Document.
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document.
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
(a)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on August 3, 2007 (File No. 001-10716).
|
|
(b)
|
|
Incorporated by reference to the Exhibits filed with our Current Report on Form 8-K filed on December 18, 2015 (File No. 001-10716).
|
|
|
|
TRIMAS CORPORATION (Registrant)
|
||
|
|
|
|
|
|
|
|
|
|
|
/s/ ROBERT J. ZALUPSKI
|
|
|
|
|
|
|
|
Date:
|
April 27, 2018
|
By:
|
|
Robert J. Zalupski
Chief Financial Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|